Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | UGT2B7 | P16662 | 2/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.30 |
| ▸ | TSHR | P16473 | 2/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19844090 | 0.76 | CYP19A1 (0.39) | CYP19A1UGT2B7PTPN1ALDH1A1CYP3A4 | |
| SCHEMBL18197939 | 0.66 | ALDH1A1 (0.48) | CYP19A1PTPN1ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL16984766 | 0.66 | ALDH1A1 (0.48) | CYP19A1PTPN1ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL3967644 | 0.66 | ALDH1A1 (0.48) | CYP19A1PTPN1ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL16982582 | 0.66 | ALDH1A1 (0.48) | CYP19A1PTPN1ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL16502918 | 0.66 | ALDH1A1 (0.48) | CYP19A1PTPN1ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL20086741 | 0.66 | ALDH1A1 (0.48) | CYP19A1PTPN1ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL3973400 | 0.66 | ALDH1A1 (0.48) | CYP19A1PTPN1ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL16984745 | 0.66 | ALDH1A1 (0.48) | CYP19A1PTPN1ALDH1A1CYP3A4CYP2C9 | |
| SCHEMBL29799288 | 0.66 | ALDH1A1 (0.48) | CYP19A1PTPN1ALDH1A1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180037912-A1 | Methods for Producing Diterpenes | UNIVERSITY OF COPENHAGEN (DK) | 2018-02-08 | — | — | US | disclosed |
| US-20180037912-A1 | Methods for Producing Diterpenes | UNIVERSITY OF COPENHAGEN (DK) | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037912-A1 | Methods for Producing Diterpenes | DHPS, COASY, FDPS | CYP19A1 65/4885UGT2B7 115/4885PTPN1 4467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.